IMA Advisory Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
IMA Advisory Services's MRNA Position: Q2 2026 in Review
IMA Advisory Services increased its Moderna (MRNA) stake by 56% in Q2 2026, buying an estimated $1.29K and bringing the position to 70 shares worth $4.9K. The position accounts for ﹤0.01% of the portfolio, ranked #913.
IMA Advisory Services first reported a position in MRNA in Q4 2022 and has held it in 3 quarters since. The position peaked at $12.2K in Q4 2022. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- IMA Advisory Services held 70 shares of Moderna worth $4.9K as of Q2 2026.
- IMA Advisory Services bought 25 Moderna shares in Q2 2026, an estimated $1.29K.
- Moderna made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #913 holding.
- IMA Advisory Services first reported a position in Moderna in Q4 2022 and has held it in 3 quarters since.
- IMA Advisory Services's Moderna position peaked at $12.2K in Q4 2022.
- 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.